v3.19.2
Initial Public Offering (Details) - USD ($)
|
|
|
6 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock sold in initial public offering, net of underwriting discounts and offering expense |
|
|
|
$ 175,378,000
|
|
$ 175,254,000
|
$ 0
|
$ 0
|
$ 175,254,000
|
|
|
|
|
|
|
|
|
Amendment of Certificate of Incorporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized (in shares) |
|
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
300,000,000
|
|
300,000,000
|
300,000,000
|
|
Common stock, par value (in USD per share) |
|
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
$ 0.01
|
|
$ 0.01
|
$ 0.01
|
|
Stock split ratio |
2.29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic Loan Assignment and Term Loan Holdings LLC Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assigned clinic loans |
|
|
|
|
|
|
$ 5,078,000
|
$ 11,082,000
|
$ 19,768,000
|
|
|
|
|
|
|
|
|
Period of weighted average maturity, clinic loans |
|
|
|
|
|
|
11 months
|
|
|
|
|
|
|
|
|
|
|
Weighted average interest rate, clinic loans |
|
|
|
|
|
|
5.12%
|
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from term loans, net of deferred financing costs |
|
|
$ 3,914,000
|
$ 1,350,000
|
$ 3,914,000
|
$ 1,350,000
|
$ 0
|
3,914,000
|
1,350,000
|
|
|
|
|
|
|
|
|
Write-off of deferred financing fees |
$ 4,708,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage tax savings payable to pre-IPO stockholders |
85.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated liability based on fair value of tax receivable agreement |
|
$ 23,400,000
|
|
|
|
|
4,952,000
|
|
|
|
|
|
|
|
|
|
|
Financial instrument fair value |
|
|
|
|
|
|
3,700,000
|
7,500,000
|
21,200,000
|
|
|
|
|
$ 23,400,000
|
|
|
$ 0
|
Accrued but unpaid obligations under tax receivable agreement |
|
|
|
|
|
|
1,252,000
|
|
|
|
|
|
|
|
|
|
|
Payments on tax receivable agreement |
|
|
|
|
|
|
6,376,000
|
878,000
|
|
|
|
|
|
|
|
|
|
Cash dividend (in dollars per share) |
$ 1.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per share (in USD per share) |
$ 28,886,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized non-cash compensation costs |
$ 38,877,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation costs recognition period, after plan modifications |
12 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation expense |
|
|
|
|
|
|
5,721,000
|
15,872,000
|
40,298,000
|
|
|
|
|
|
|
|
|
Second Lien Credit Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock sold in initial public offering, net of underwriting discounts and offering expense |
$ 165,635,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Lien Credit Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction costs |
1,350,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in borrowing capacity |
50,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate amount of borrowing capacity |
$ 100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate margin increase |
0.25%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from term loans, net of deferred financing costs |
$ 2,700,000
|
|
|
|
|
|
1,350,000
|
|
|
|
|
|
|
|
|
|
|
Term loans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in borrowing capacity |
$ 60,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guaranteed Clinic Loan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic Loan Assignment and Term Loan Holdings LLC Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic loan guarantee |
|
|
|
|
|
|
2,813,000
|
5,854,000
|
10,473,000
|
|
|
|
|
|
|
|
|
IPO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares sold in public offering (in shares) |
8,625,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share price (in USD per share) |
$ 22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock sold in initial public offering, net of underwriting discounts and offering expense |
$ 176,942,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction costs |
|
|
|
|
|
|
|
2,239,000
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation due to modification |
|
|
|
|
|
|
|
$ 11,749,000
|
36,368,000
|
|
|
|
|
|
|
|
|
Stock compensation expense |
|
|
|
|
|
|
|
|
$ 586,000
|
|
|
|
|
|
|
|
|
Vested Option Stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equivalent adjustments in the form of cash dividend equivalent payments (in dollars per share) |
$ 1.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equitable adjustments in the form of cash dividend equivalent payments |
|
|
|
|
|
|
5,341,000
|
|
|
|
|
|
|
|
|
|
|
Vested Option Stockholders | Term Loan Holdings LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equitable adjustments in the form of cash dividend equivalent payments |
|
|
|
|
|
|
$ 2,524,000
|
|
|
|
|
|
|
|
|
|
|
Unvested Option Stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendments to and Repayment of Credit Facilities, Income Tax Receivable Agreement and Special Dividends and Stock Option Modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equitable adjustments in the form of cash dividend equivalent payments |
$ 1,385,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic Loan Assignment and Term Loan Holdings LLC Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
|
|
|
|
4.25%
|
|
|
|
|
|
|
|
|
|
|
Minimum | Term loans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic Loan Assignment and Term Loan Holdings LLC Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
|
|
|
|
3.31%
|
|
|
|
|
|
|
|
|
|
|
Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic Loan Assignment and Term Loan Holdings LLC Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
|
|
|
|
8.08%
|
|
|
|
|
|
|
|
|
|
|
Maximum | Term loans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinic Loan Assignment and Term Loan Holdings LLC Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
|
|
|
|
7.98%
|
|
|
|
|
|
|
|
|
|
|
X |
- DefinitionRepresents the amount of the assigned clinic loans guaranteed in proportion to the respective ownership interests.
+ References
+ Details
Name: |
ara_ClinicLoanGuarantee |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of paid and unpaid common stock dividends declared with the form of settlement in cash (in dollars per share).
+ References
+ Details
Name: |
ara_DividendsCashPerShare |
Namespace Prefix: |
ara_ |
Data Type: |
num:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDividend equivalent payments on certain stock options.
+ References
+ Details
Name: |
ara_EquitableAdjustmentCashDividendEquivalentPayment |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionRepresents dividend equivalent payments on certain stock options per share amount.
+ References
+ Details
Name: |
ara_EquitableAdjustmentCashDividendEquivalentPaymentPerShare |
Namespace Prefix: |
ara_ |
Data Type: |
num:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionPayments On Tax Receivable Agreement
+ References
+ Details
Name: |
ara_PaymentsOnTaxReceivableAgreement |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe percentage of cash savings in U.S. federal, state and local income tax realized as a result of any deductions (including net operating losses resulting from such deductions) attributable to the exercise of (or any payment, including any dividend equivalent right or payment, in respect of) any compensatory stock option issued payable to our pre-IPO stockholders on a pro rata basis.
+ References
+ Details
Name: |
ara_PercentageTaxSavingsPayableToStockholders |
Namespace Prefix: |
ara_ |
Data Type: |
num:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average maturity (weighted by amount of the agreement), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
+ Details
Name: |
ara_PeriodOfWeightedAverageMaturity |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition[Line Items] for Schedule of Initial Public Offering [Table]
+ References
+ Details
Name: |
ara_ScheduleofInitialPublicOfferingLineItems |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionShare-Based Compensation Arrangement By Share-Based Payment Award, Plan Modification, Period For Cost Recognition
+ References
+ Details
Name: |
ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationPeriodForCostRecognition |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCosts associated with debt refinancing and other IPO related transactions. These costs include legal, accounting, valuation and other professional or consulting fees.
+ References
+ Details
Name: |
ara_TransactionCosts |
Namespace Prefix: |
ara_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
+ Details
Name: |
us-gaap_AllocatedShareBasedCompensationExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFace amount or stated value per share of common stock.
+ References
+ Details
Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
num:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
+ Details
Name: |
us-gaap_CommonStockSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionIncremental percentage increase (decrease) in the stated rate on a debt instrument.
+ References
+ Details
Name: |
us-gaap_DebtInstrumentInterestRateIncreaseDecrease |
Namespace Prefix: |
us-gaap_ |
Data Type: |
num:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionContractual interest rate for funds borrowed, under the debt agreement.
+ References
+ Details
Name: |
us-gaap_DebtInstrumentInterestRateStatedPercentage |
Namespace Prefix: |
us-gaap_ |
Data Type: |
num:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average interest rate of debt outstanding.
+ References
+ Details
Name: |
us-gaap_DebtWeightedAverageInterestRate |
Namespace Prefix: |
us-gaap_ |
Data Type: |
num:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAmount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.
+ References
+ Details
Name: |
us-gaap_DividendsCash |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cost to be recognized for option under share-based payment arrangement.
+ References
+ Details
Name: |
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionMaximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.
+ References
+ Details
Name: |
us-gaap_GuaranteeObligationsMaximumExposure |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of increase (decrease) of the credit facility.
+ References
+ Details
Name: |
us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
+ Details
Name: |
us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
+ References
+ Details
Name: |
us-gaap_PaymentsOfDebtIssuanceCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
+ Details
Name: |
us-gaap_ProceedsFromIssuanceInitialPublicOffering |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAn excess of the fair value of the modified award over the fair value of the award immediately before the modification.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionPrice of a single share of a number of saleable stocks of a company.
+ References
+ Details
Name: |
us-gaap_SharePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
num:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of new stock issued during the period.
+ References
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesNewIssues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionRatio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.
+ References
+ Details
Name: |
us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:pureItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWrite-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.
+ References
+ Details
Name: |
us-gaap_WriteOffOfDeferredDebtIssuanceCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_LongtermDebtTypeAxis=ara_SecondLienCreditAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_LongtermDebtTypeAxis=ara_FirstLienCreditAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_GuaranteeOfIndebtednessOfOthersMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_SubsidiarySaleOfStockAxis=ara_VestedOptionStockholdersMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
dei_LegalEntityAxis=ara_TermLoanHoldingsLLCMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_SubsidiarySaleOfStockAxis=ara_UnvestedOptionStockholdersMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MinimumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
|